Author:
Janssens Peter,Arnaud Laurent,Galicier Lionel,Mathian Alexis,Hie Miguel,Sene Damien,Haroche Julien,Veyssier-Belot Catherine,Huynh-Charlier Isabelle,Grenier Philippe A,Piette Jean-Charles,Amoura Zahir
Abstract
Abstract
Lupus enteritis is a rare and poorly understood cause of abdominal pain in patients with systemic lupus erythematosus (SLE). In this study, we report a series of 7 new patients with this rare condition who were referred to French tertiary care centers and perform a systematic literature review of SLE cases fulfilling the revised ACR criteria, with evidence for small bowel involvement, excluding those with infectious enteritis. We describe the characteristics of 143 previously published and 7 new cases. Clinical symptoms mostly included abdominal pain (97%), vomiting (42%), diarrhea (32%) and fever (20%). Laboratory features mostly reflected lupus activity: low complement levels (88%), anemia (52%), leukocytopenia or lymphocytopenia (40%) and thrombocytopenia (21%). Median CRP level was 2.0 mg/dL (range 0–8.2 mg/dL). Proteinuria was present in 47% of cases. Imaging studies revealed bowel wall edema (95%), ascites (78%), the characteristic target sign (71%), mesenteric abnormalities (71%) and bowel dilatation (24%). Only 9 patients (6%) had histologically confirmed vasculitis. All patients received corticosteroids as a first-line therapy, with additional immunosuppressants administered either from the initial episode or only in case of relapse (recurrence rate: 25%). Seven percent developed intestinal necrosis or perforation, yielding a mortality rate of 2.7%. Altogether, lupus enteritis is a poorly known cause of abdominal pain in SLE patients, with distinct clinical and therapeutic features. The disease may evolve to intestinal necrosis and perforation if untreated. Adding with this an excellent steroid responsiveness, timely diagnosis becomes primordial for the adequate management of this rare entity.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Genetics(clinical),General Medicine
Reference60 articles.
1. Kwok SK, Seo SH, Ju JH, Park KS, Yoon CH, Kim WU, Min JK, Park SH, Cho CS, Kim HY: Lupus enteritis: clinical characteristics, risk factor for relapse and association with anti-endothelial cell antibody. Lupus. 2007, 16 (10): 803-809. 10.1177/0961203307082383.
2. Breuer GS, Baer A, Dahan D, Nesher G: Lupus-associated pancreatitis. Autoimmun Rev. 2006, 5 (5): 314-318. 10.1016/j.autrev.2005.11.004.
3. Hallegua DS, Wallace DJ: Gastrointestinal manifestations of systemic lupus erythematosus. Curr Opin Rheumatol. 2000, 12 (5): 379-385. 10.1097/00002281-200009000-00005.
4. Cacoub P, Benhamou Y, Barbet P, Piette JC, Le Cae A, Chaussade S, Cadranel JF, Callard P, Opolon P, Godeau P: Systemic lupus erythematosus and chronic intestinal pseudoobstruction. J Rheumatol. 1993, 20 (2): 377-381.
5. Sultan SM, Ioannou Y, Isenberg DA: A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatology (Oxford). 1999, 38 (10): 917-932. 10.1093/rheumatology/38.10.917.
Cited by
112 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献